Use of cancer chemopreventive phytochemicals as antineoplastic agents

Lancet Oncology

Volumn 6, Issue 11, 2005, Pages 899-904

  D'Incalci, Maurizio ^a   Steward, William P ^b   Gescher, Andreas J ^b  

^a MARIO NEGRI INSTITUTE FOR PHARMACOLOGICAL RESEARCH   (Italy)

^b UNIVERSITY OF LEICESTER   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

3 INDOLEMETHANOL; ANTINEOPLASTIC AGENT; CETUXIMAB; CURCUMIN; CYCLOPHOSPHAMIDE; CYTOTOXIC AGENT; EPIGALLOCATECHIN GALLATE; ERLOTINIB; GEFITINIB; IMATINIB; ISOFLAVONE; RESVERATROL; TAMOXIFEN; TRASTUZUMAB;

ARTICLE; CANCER CELL; CANCER PREVENTION; CHEMOPROPHYLAXIS; DRUG BIOAVAILABILITY; DRUG SENSITIZATION; HOST RESISTANCE; HUMAN; NONHUMAN; PRIORITY JOURNAL;

EID: 27744511607     PISSN: 14702045     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1470-2045(05)70425-3     Document Type: Note

References (51)

1. YJ Surh Cancer chemoprevention with dietary phytochemicals Nat Rev Cancer 3 2003 768-780
2. T Dorai BB Aggarwal Role of chemopreventive agents in cancer therapy Cancer Lett 215 2004 129-140
3. D Hanahan RA Weinberg The hallmarks of cancer Cell 100 2000 57-70
4. S Pal T Choudhuri S Chattopadhyay et al. Mechanisms of curcumin-induced apoptosis of Ehrlich's ascites carcinoma cells Biochem Biophys Res Commun 288 2001 658-665
5. D Delmas C Rebe S Lacour et al. Resveratrol-induced apoptosis is associated with Fas redistribution in the rafts and the formation of a death-inducing signaling complex in colon cancer cells J Biol Chem 278 2003 41482-41490
6. GP Collett FC Campbell Curcumin induces c-jun N-terminal kinase-dependent apoptosis in HCT116 human colon cancer cells Carcinogenesis 25 2004 2183-2189
7. AS Jaiswal BP Marlow N Gupta S Narayan β-catenin-mediated transactivation and cell-cell adhesion pathways are important in curcumin (diferuylmethane)-induced growth arrest and apoptosis in colon cancer cells Oncogene 21 2002 8414-8427
8. A Chen J Xu Activation of PPAR-γ by curcumin inhibits Moser cell growth and mediates suppression of gene expression of cyclin D1 and EGFR Am J Physiol Gastrointest Liver Physiol 288 2005 G447-G456
9. MJ Park EH Kim IC Park et al. Curcumin inhibits cell cycle progression of immortalized human umbilical vein endothelial (ECV304) cells by up-regulating cyclin-dependent kinase inhibitors, p21(WAF1/CIP1), p27(KIP1) and p53 Int J Oncol 21 2002 379-383
10. Y Takada A Bhardwaj P Potdar BB Aggarwal Nonsteroidal anti-inflammatory agents differ in their ability to suppress NF-kappa B activation, inhibition of expression of cyclooxygenase-2 and cyclin D1, and abrogation of tumor cell proliferation Oncogene 23 2004 9247-9258
11. SK Manna A Mukhopadhyay BB Aggarwal Resveratrol suppresses TNF-induced activation of nuclear transcription factors NF-kappa B, activator protein-1, and apoptosis: Potential role of reactive oxygen intermediates and lipid peroxidation J Immunol 164 2000 6509-6519
12. AK Joe H Liu M Suzui et al. Resveratrol induces growth inhibition, S-phase arrest, apoptosis, and changes in biomarker expression in several human cancer cell lines Clin Cancer Res 8 2002 893-903
13. N Ahmad S Gupta H Mukhtar Green tea polyphenol epigallocatechin-3-gallate differentially modulates nuclear factorκB in cancer cells versus normal cells Arch Biochem Biophys 376 2000 338-346
14. FH Sarkar KMW Rahman YW Li Bax translocation to mitochondria is an important event in inducing apoptotic cell death by indole-3-carbinol (I3C) treatment of breast cancer cells J Nutr 133 suppl 2003 S2434-S2439
15. LM Howells B Gallacher-Horley CE Houghton et al. Indole-3-carbinol inhibits protein kinase B/Akt and induces apoptosis in the human breast tumor cell line MDA MB468 but not in the nontumorigenic HBL100 line Mol Cancer Ther 1 2002 1161-1172
16. JC Reed Apoptosis-targeted therapies for cancer Cancer Cell 3 2003 17-22
17. I Naasani H Seimiya T Tsuruo Telomerase inhibition, telomere shortening, and senescence of cancer cells by tea catechins Biochem Biophys Res Commun 249 1998 391-396
18. E Navarro-Peran J Cabezas-Herrera F Garcia-Canovas et al. The antifolate activity of tea catechins Cancer Res 65 2005 2059-2064
19. MZ Fang YM Wang N Ai et al. Tea polyphenol (-)-epigallocatechin-3-gallate inhibits DNA methyltransferase and reactivates methylation-silenced genes in cancer cell lines Cancer Res 63 2003 7563-7570
20. KJ Auborn S Fan EM Rosen et al. Indole-3-carbinol is a negative regulator of estrogen J Nutr 133 suppl 2003 S2470-S2475
21. P Allavena M Signorelli M Chieppa et al. Anti-inflammatory properties of the novel antitumor agent yondelis (trabectedin): Inhibition of macrophage differentiation and cytokine production Cancer Res 65 2005 2964-2971
22. SM Plummer KA Holloway MM Manson et al. Inhibition of cyclooxygenase 2 expression in colon cells by the chemopreventive agent curcumin involves inhibition of NF-kappaB activation via the NIK/IKK signalling complex Oncogene 18 1999 6013-6020
23. K Subbaramaiah WJ Chung P Michaluart et al. Resveratrol inhibits cyclooxygenase-2 transcription and activity in phorbol ester-treated human mammary epithelial cells J Biol Chem 273 1998 21875-21882
24. A Arora K Seth N Kalra Y Shukla Modulation of P-glycoprotein-mediated multidrug resistance in K562 leukemic cells by indole-3-carbinol Toxicol Appl Pharmacol 202 2005 237-243
25. A Arora Y Shukla Modulation of vinca alkaloid induced P-glycoprotein expression by indole-3-carbinol Cancer Lett 189 2003 167-173
26. W Chearwae S Anuchapreeda K Nandigama et al. Biochemical mechanism of modulation of human P-glycoprotein (ABCB1) by curcumin I, II and III purified from turmeric powder Biochem Pharmacol 68 2004 2043-2052
27. P Limtrakul S Anuchapreeda D Buddhasukh Modulation of human multidrug-resistance MDR-1 gene by natural curcuminoids BMC Cancer 4 2004 13
28. N Romiti R Tongiani F Cervelli E Chieli Effects of curcumin on P-glycoprotein in primary cultures of rat hepatocytes Life Sci 62 1998 2349-2358
29. HM Wortelboer M Usta AE Van der Velde et al. Interplay between MRP inhibition and metabolism of MRP inhibitors: The case of curcumin Chem Res Toxicol 16 2003 1642-1651
30. J Jodoin M Demeule R Beliveau Inhibition of the multidrug resistance P-glycoprotein activity by green tea polyphenols Biochim Biophys Acta 1542 2002 149-159
31. Y Sadzuka T Sugiyama T Sonobe Efficacies of tea components on doxorubicin induced antitumour activity and reversal of multidrug resistance Toxicol Lett 114 2000 155-162
32. Y Mei F Qian D Wei J Liu Reversal of cancer multidrug resistance by green tea polyphenols J Pharm Pharmacol 56 2004 1307-1314
33. T Nabekura S Kamiyama S Kitagawa Effects of dietary chemopreventive phytochemicals on P-glycoprotein function Biochem Biophys Res Commun 327 2005 866-870
34. JG Christensen GA LeBlanc Reversal of multidrug resistance in vivo by dietary administration of the phytochemical indole-3-carbinol Cancer Res 56 1996 574-581
35. Q Zhang D Wei J Liu In vivo reversal of doxorubicin resistance by (-)-epigallocatechin gallate in a solid human carcinoma xenograft Cancer Lett 208 2004 179-186
36. S Donald RD Verschoyle P Greaves et al. Dietary agent indole-3-carbinol protects female rats against the hepatotoxicity of the antitumor drug ET-743 (trabectidin) without compromising efficacy in a rat mammary carcinoma Int J Cancer 111 2004 961-967
37. RA Sharma SA Euden SL Platton et al. Phase I clinical trial of oral curcumin: Biomarkers of systemic activity and compliance Clin Cancer Res 10 2004 6847-6854
38. G Garcea DP Berry DJL Jones et al. Consumption of the putative chemopreventive agent curcumin by cancer patients: Assessment of curcumin levels in the colorectum and their pharmacodynamic consequences Cancer Epidemiol Biomarkers Prev 14 2005 120-125
39. AL Cheng CH Hsu JK Lin et al. Phase I clinical trial of curcumin, a chemopreventive agent, in patients with high-risk or pre-malignant lesions Anticancer Res 21 2001 2895-2900
40. DA Goldberg J Yan GJ Soleas Absorption of three wine-related polyphenols in three different matrices by healthy subjects Clin Biochem 36 2003 79-87
41. T Walle F Hsieh MH DeLegge et al. High absorption but very low bioavailability of oral resveratrol in humans Drug Metab Dispos 32 2004 1377-1382
42. U Ullmann J Haller JP Decourt et al. A single ascending dose study of epigallocatechin gallate in healthy volunteers J Int Med Res 31 2003 88-101
43. HHS Chow Y Cai IA Hakim et al. Pharmacokinetics and safety of green tea polyphenols after multiple-dose administration of epigallocatechin gallate and polyphenon E in healthy individuals Clin Cancer Res 9 2003 3312-3319
44. MJ Anderton MM Manson RD Verschoyle et al. Pharmacokinetics and tissue disposition of indole-3-carbinol and its acid condensation products after oral administration to mice Clin Cancer Res 10 2004 5233-5241
45. M Masuda M Suzui IB Weinstein Effects of epigallocatechin-3-gallate on growth, epidermal growth factor receptor signaling pathways, gene expression and chemosensitivity in human head and neck squamous cell carcinoma cell lines Clin Cancer Res 7 2001 4220-4229
46. S Somasundaram NA Edmund DT Moore et al. Dietary curcumin inhibits chemotherapy-induced apoptosis in models of human breast cancer Cancer Res 62 2002 3868-3875
47. B Liu S Edgerton X Yang et al. Low-dose dietary phytoestrogen abrogates tamoxifen-associated mammary tumor prevention Cancer Res 65 2005 879-886
48. JL Abbruzzese SM Lippman The convergence of cancer prevention and therapy in early-phase clinical drug development Cancer Cell 6 2004 321-326
49. AJ Gescher WP Steward Relationship between mechanisms, bioavailibility, and preclinical chemopreventive efficacy of resveratrol: A conundrum Cancer Epidemiol Biomarkers Prev 12 2003 953-957
50. A Jatoi N Ellison PA Burch et al. A phase II trial of green tea in the treatment of patients with androgen independent metastatic prostate carcinoma Cancer 97 2003 1442-1446
51. BA Chabner The miracle of Iressa Oncologist 9 2004 245-246